Andreasson Lab News

Featured News

The lab sets sail

  • 6/26/2025: The Andreasson Lab’s maiden voyage into the Monterey Bay on a Whale Watching trip encountered humpbacks, sea otters, birds, and even jellyfish! Nobody fell off the boat.

  • Andreasson, K. (2025, February 27). Restoring glucose metabolism: a new approach to reversing cognitive decline in AD [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 4, 2025, from https://doi.org/10.69645/SHCV5144.

News

The Search

Four Stanford efforts to better detect, understand, and defeat Alzheimer’s disease are examined. Michael Greicius, MD, MPH, discusses a rare APOE variant that may point toward new treatments. Elizabeth Mormino, PhD, and Tony Wyss-Coray, PhD, describe the Stanford Aging and Memory Study and the search for what makes some brains resilient. Katrin Andreasson, MD, explains how inflammation may deprive the brain of energy, and Frank M. Longo, MD, PhD, discusses efforts to protect synaptic connections. Sharon Sha, MD, MS, chief of the Memory Disorders Division, also comments.

Breakdown of immune cells’ interaction is key driver in aging, study finds

Stanford Medicine researchers have identified a key driver of aging: a breakdown in how immune cells clean up after each other. As we age, tissue-resident macrophages lose their ability to clear out worn-out neutrophils, letting inflammation build across the body. Blocking a single receptor on these macrophages kept mice's organs, including the brain, heart and liver, looking and functioning younger, and slowed cognitive decline. The findings point to a possible drug target for extending healthy aging.

Knight Initiative for Brain Resilience Symposium Spring 2026

Slowing aging, predicting lifespan, and excitement for the future were topics at the Knight Initiative spring symposium, which showcased research ranging from rejuvenating the brain’s immune system to predicting cognitive health, and celebrated the next chapter of the Knight Initiative.

Is Alzheimer's an energy crisis in the brain?

For decades, Alzheimer's research has focused on clearing amyloid plaques from the brain. But new drugs that successfully remove plaques have proven disappointingly ineffective for patients, leaving the field searching for alternative approaches. Stanford Medicine neurologist Kati Andreasson has spent twenty years pursuing a different path.

Immune-Metabolic Mechanisms of Cognitive Decline in Aging

Dr. Katrin Andreasson presents at the 10th Aging Research and Drug Discovery (ARDD2023) conference, discussing immune-metabolic mechanisms underlying cognitive decline in aging.

Can Science De-Age the Brain?

HealthCall's Lee Kelso speaks with Dr. Andreasson about how experiments in mice targeting the brain's metabolic pathways could lead to treatments for Alzheimer's disease.

Drugs that improve brain metabolism could help Alzheimer’s patients

Targeting a metabolic pathway well-known in cancer research, neuroscientists at Stanford believe they may have found a way to improve brain performance in Alzheimer’s patients.

Arc Institute Ignite Award

Congratulations, Katrin  Andreasson, MD on receiving a 2023 Arc Institute Ignite Award.  Award recipients were selected for their visionary research agendas that venture into little-explored territory. Their expertise complements work happening at Arc and explores focus areas from distinct angles, opening up additional channels for discovery and impact. Dr. Andreasson's grant will investigate the role of dysregulated inflammatory responses that drive age-associated cognitive decline and neurodegenerative diseases.  A primary focus will be on the peripheral innate immune response and how it changes in aging and age-associated inflammatory diseases.  

Simons Foundation Grant

Congratulations, Chinyere Agbaegbu Iweka, PhD, on receiving a Simons Foundation Independence Award for her work "Circadian regulation of immune cell metabolism and the effect on cognitive flexibility in the aging brain"

Bold ideas to advance healthy brain aging win inaugural Knight Initiative grants

The Phil and Penny Knight Initiative for Brain Resilience is proud to announce the recipients of its inaugural 2022 Innovation and Catalyst Grants.

Q&A: How the aging immune system impacts brain health

Katrin Andreasson discusses how immune cells can cause harmful brain inflammation and contribute to the development of neurodegenerative diseases like Alzheimer’s disease.

Special meeting with Professor Condoleezza Rice

Stanford University Postdoctoral Association (SURPAS) sponsored a special Q & A meeting with Professor Condoleezza Rice & Chinyere Agbaegbu Iweka, PhD, SURPAS Co-chair.

Second cohort of CZ Biohub Investigators includes 33 Stanford faculty

Dr. Katrin Andreasson was selected from nearly 700 applicants as a Chan Zuckerberg Biohub Investigator. The Investigator Program, open to faculty members at Stanford University, UC San Francisco, and UC Berkeley, awards $1 million in unrestricted funds over five years to each Investigator, with the goal of building engaged, collaborative communities of Bay Area scientists to undertake creative and innovative research that will help solve the biggest challenges in biomedicine.

Chinyere Iweka Recognized with Stanford Postdoc JEDI Champion Award

"Instead of our differences bringing us together, it tears us apart. We hide and live in fear instead of embracing and celebrating ourselves. Meetings to discuss race, equity, inclusion and justice, emails expressing shock and horror about the evil people do on account of race and religion, mean nothing if we follow through with no tangible action. If I can make one person feel respected, accepted and empowered and perhaps pass the feeling along, then I have achieved my goal. Even the smallest acts can make a significant difference."

Study reveals immune driver of brain aging

Scientists have identified a key factor in mental aging and shown that it might be prevented or reversed by fixing a glitch in the immune system’s front-line soldiers.

New Method for Tackling Stroke Restrains an Overactive Immune System

Shutting down an inflammatory molecule could potentially provide treatment days after onset.

Scientists shrink stroke damage in mice by calming immune cells outside brain

Instead of trying to fix stroke-damaged nerve cells, Stanford scientists took aim at a set of first-responder immune cells that live outside the brain but rush to the site of a stroke. It worked.

Boosting the Brain's Immune System - Dr. Katrin Andreasson

Previous research has shown that NSAIDS, a class of anti-inflammatory drug, can help prevent Alzheimer’s in cognitively normal people, but it wasn’t clear why. NSAIDs do not work once any memory loss has begun, so this is a real preventive effect. Now, exciting new research has identified a potential culprit - malfunctioning immune cells in the brain. This discovery has opened up new avenues for treatment.

Brain Traffic Control

With new brain-scanning methods, scientists aim to make Alzheimer’s disease history

Alzheimer’s Disease: What Stands Between Us and a Cure?

Our understanding of Alzheimer’s disease is better than ever before. So why are we still so far from a cure?

Blocking receptor in brain's immune cells counters Alzheimer's in mice, study finds

Brain cells called microglia chew up toxic substances and cell debris, calm inflammation and make nerve-cell-nurturing substances. New research shows that keeping them on the job may prevent neurodegeneration.

Contact Us

Annie Shiau
ashiau@stanford.edu